Biosenta Inc. (CSE:ZRO)
Canada
· Delayed Price · Currency is CAD 0.0750
-0.0100 (-11.76%)
Mar 4, 2026, 5:13 PM EST
Biosenta Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Revenue | 0 | 0 | 0 | 0 | 0 | 0.17 | Upgrade
|
| Revenue Growth (YoY) | -43.68% | -12.18% | 32.34% | -9.47% | -99.31% | 10887.26% | Upgrade
|
| Cost of Revenue | 0 | 0 | 0 | 0 | 0.03 | 0.08 | Upgrade
|
| Gross Profit | 0 | 0 | 0 | -0 | -0.03 | 0.09 | Upgrade
|
| Selling, General & Admin | 1.22 | 1.19 | 1.06 | 1.41 | 1.08 | 2.02 | Upgrade
|
| Research & Development | 0.05 | 0.03 | 0.04 | 0.07 | 0.1 | 0.08 | Upgrade
|
| Operating Expenses | 1.27 | 1.23 | 1.1 | 1.48 | 1.19 | 2.1 | Upgrade
|
| Operating Income | -1.27 | -1.23 | -1.1 | -1.48 | -1.22 | -2.01 | Upgrade
|
| Interest Expense | -1.08 | -1.12 | -1.13 | -0.06 | -0.22 | -0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | -0 | 0 | 0 | -0.01 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.17 | -0.16 | 0.01 | 0.03 | -0.01 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -2.51 | -2.51 | -2.23 | -1.51 | -1.46 | -2.04 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -4.79 | - | - | Upgrade
|
| Pretax Income | -2.51 | -2.51 | -2.23 | -6.3 | -1.46 | -2.04 | Upgrade
|
| Net Income | -2.51 | -2.51 | -2.23 | -6.3 | -1.46 | -2.04 | Upgrade
|
| Net Income to Common | -2.51 | -2.51 | -2.23 | -6.3 | -1.46 | -2.04 | Upgrade
|
| Shares Outstanding (Basic) | 33 | 33 | 30 | 26 | 21 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 33 | 30 | 26 | 21 | 18 | Upgrade
|
| Shares Change (YoY) | 7.41% | 12.54% | 13.05% | 22.74% | 19.71% | 11.27% | Upgrade
|
| EPS (Basic) | -0.08 | -0.08 | -0.08 | -0.24 | -0.07 | -0.11 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.08 | -0.08 | -0.24 | -0.07 | -0.11 | Upgrade
|
| Free Cash Flow | -0.45 | -0.48 | -0.78 | -0.57 | -0.5 | -0.67 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.02 | -0.02 | -0.04 | Upgrade
|
| Gross Margin | 42.45% | 46.82% | 60.55% | -291.36% | - | 54.23% | Upgrade
|
| Operating Margin | -134646.70% | -101556.48% | -80027.12% | -142275.24% | -105790.62% | -1194.37% | Upgrade
|
| Profit Margin | -267469.15% | -206924.36% | -161543.00% | -604582.92% | -126695.14% | -1214.64% | Upgrade
|
| Free Cash Flow Margin | -47725.11% | -39738.81% | -56515.45% | -54351.92% | -43825.63% | -399.92% | Upgrade
|
| EBITDA | -1.26 | -1.23 | -1.1 | - | - | - | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | - | - | - | Upgrade
|
| EBIT | -1.27 | -1.23 | -1.1 | -1.48 | -1.22 | -2.01 | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 0.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.